首页> 外文期刊>Epilepsia: Journal of the International League against Epilepsy >Duration of therapeutic coma and outcome of refractory status epilepticus
【24h】

Duration of therapeutic coma and outcome of refractory status epilepticus

机译:治疗昏迷的持续时间和难治性状态癫痫的结果

获取原文
获取原文并翻译 | 示例
       

摘要

Summary Objective Examine the association of duration of therapeutic coma ( TC ) with seizure recurrence, morbidity, and mortality in refractory status epilepticus ( RSE ). Define an optimal window for TC that provides sustained seizure control and minimizes complications. Methods Retrospective, observational cohort study involving patients who presented with RSE to the University of Alabama at Birmingham or the University of California at San Francisco from 2010 to 2016. Relationship of duration of TC with primary and secondary outcomes was evaluated using two‐sample t tests, simple linear regression, and chi‐square tests. Multivariable linear and logistic regression models were used to identify independent predictors. Predictive ability of TC for seizure recurrence was quantified using a receiver‐operating characteristic curve. Youden index was used to determine an optimal cutoff value. Results Multivariable analysis of clinical and treatment characteristics of 182 patients who were treated predominantly with propofol as anesthetic agent showed that longer duration of the first trial of TC (27.2 vs 15.6?hours) was independently associated with a higher chance of seizure recurrence following the first weaning attempt ( P? = ? 0.038) but not with poor functional neurologic outcome upon discharge, in‐hospital complications, or mortality. Furthermore, higher doses of anesthetic utilized during the first trial of TC were independently associated with fewer in‐hospital complications ( P? = ? 0.003) and associated with a shorter duration of mechanical ventilation and total length of stay. Duration of TC was identified as an independent predictor of seizure recurrence with an optimal cutoff point at 35?hours. Significance This study suggests that a shorter duration yet deeper TC as treatment for RSE may be more effective and safer than the currently recommended TC duration of 24‐48?hours. Prospective and randomized trials should be conducted to validate these assertions.
机译:发明内容目的审查治疗性昏迷(TC)的持续时间与癫痫发作,发病率和难治性状态癫痫症(RSE)的死亡率。为TC定义一个最佳窗口,可提供持续的癫痫管道并最大限度地减少并发症。方法回顾性,观察队列研究涉及将RSE与伯明翰大学或2010年到2016年旧金山大学向阿拉巴马大学提供的患者。使用两种样品T检验评估TC的持续时间和二次结果的关系,简单的线性回归和chi-square测试。多变量线性和逻辑回归模型用于识别独立预测因子。使用接收器操作特性曲线量化TC用于癫痫发作的预测能力。 YENEN索引用于确定最佳截止值。结果多变量分析临床和治疗特征的182名患者主要用异丙酚治疗的麻醉剂表明,TC的第一次试验的持续时间较长(27.2 vs15.6?小时)与第一个断奶尝试(p?= 0.038),但在排出,院内并发症或死亡率时不具有差的功能性神经系统结果。此外,在TC的第一次试验期间使用的较高剂量的麻醉剂与较少的院内并发症(P?= 0.003)独立相关,并且与机械通气的持续时间较短,并且总持续时间。 TC的持续时间被鉴定为癫痫发作复发的独立预测因子,在35℃下具有最佳截止点。这项研究表明,作为RSE的治疗更越来越较短的TC,比目前推荐的TC持续时间更为有效,更安全,更加有效,更安全。应进行前瞻性和随机试验以验证这些断言。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号